Literature DB >> 18031233

SUMO: getting it on.

J Anckar1, L Sistonen.   

Abstract

Post-translational modification of cellular proteins by the SUMO (small ubiquitin-related modifier) is involved in numerous modes of regulation in widely different biological processes. In contrast with ubiquitination, SUMO conjugation is highly specific in terms of target lysine residues, but many aspects of substrate and lysine selection by the SUMO conjugating machinery are still poorly understood. SUMOylation events usually occur on the PsiKXE SUMO consensus motifs, which mediate binding to Ubc9 (ubiquitin-conjugating enzyme 9), the SUMO E2 conjugating enzyme. Although most, if not all, SUMO conjugations are catalysed by Ubc9, far from all PsiKXE tetrapeptides are modified, demonstrating a need for additional specificity determinants in SUMOylation. Recent results intimately link regulation of SUMOylation to other post-translational modifications, including phosphorylation and acetylation and reveal that certain lysine residues are marked for SUMOylation by negatively charged amino acid residues or phosphorylation events immediately downstream of the consensus site. In the present review, we explore the intriguing role of extended motifs in the regulation of SUMO conjugation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18031233     DOI: 10.1042/BST0351409

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  43 in total

1.  The CTCF insulator protein is posttranslationally modified by SUMO.

Authors:  Melissa J MacPherson; Linda G Beatty; Wenjing Zhou; Minjie Du; Paul D Sadowski
Journal:  Mol Cell Biol       Date:  2008-11-24       Impact factor: 4.272

2.  Mechanisms underlying the control of progesterone receptor transcriptional activity by SUMOylation.

Authors:  Hany Abdel-Hafiz; Michelle L Dudevoir; Kathryn B Horwitz
Journal:  J Biol Chem       Date:  2009-02-11       Impact factor: 5.157

3.  Novel proteomics strategy brings insight into the prevalence of SUMO-2 target sites.

Authors:  Henri A Blomster; Ville Hietakangas; Jianmin Wu; Petri Kouvonen; Sampsa Hautaniemi; Lea Sistonen
Journal:  Mol Cell Proteomics       Date:  2009-02-24       Impact factor: 5.911

Review 4.  Transcellular chaperone signaling: an organismal strategy for integrated cell stress responses.

Authors:  Patricija van Oosten-Hawle; Richard I Morimoto
Journal:  J Exp Biol       Date:  2014-01-01       Impact factor: 3.312

5.  Nuclear PTEN controls DNA repair and sensitivity to genotoxic stress.

Authors:  C Bassi; J Ho; T Srikumar; R J O Dowling; C Gorrini; S J Miller; T W Mak; B G Neel; B Raught; V Stambolic
Journal:  Science       Date:  2013-07-26       Impact factor: 47.728

6.  Phosphorylation-dependent interaction of SATB1 and PIAS1 directs SUMO-regulated caspase cleavage of SATB1.

Authors:  Joseph-Anthony T Tan; Jing Song; Yuan Chen; Linda K Durrin
Journal:  Mol Cell Biol       Date:  2010-03-29       Impact factor: 4.272

Review 7.  PIAS proteins: pleiotropic interactors associated with SUMO.

Authors:  Miia M Rytinki; Sanna Kaikkonen; Petri Pehkonen; Tiina Jääskeläinen; Jorma J Palvimo
Journal:  Cell Mol Life Sci       Date:  2009-06-13       Impact factor: 9.261

8.  Sumoylation of the Epstein-Barr virus BZLF1 protein inhibits its transcriptional activity and is regulated by the virus-encoded protein kinase.

Authors:  Stacy R Hagemeier; Sarah J Dickerson; Qiao Meng; Xianming Yu; Janet E Mertz; Shannon C Kenney
Journal:  J Virol       Date:  2010-02-24       Impact factor: 5.103

9.  Structural diversity and evolution of the N-terminal isoform-specific region of ecdysone receptor-A and -B1 isoforms in insects.

Authors:  Takayuki Watanabe; Hideaki Takeuchi; Takeo Kubo
Journal:  BMC Evol Biol       Date:  2010-02-12       Impact factor: 3.260

Review 10.  A manually curated network of the PML nuclear body interactome reveals an important role for PML-NBs in SUMOylation dynamics.

Authors:  Ellen Van Damme; Kris Laukens; Thanh Hai Dang; Xaveer Van Ostade
Journal:  Int J Biol Sci       Date:  2010-01-12       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.